Fatty Liver due to NASH and Obeticholic Acid (Trade name: Ocaliva)Research Question:
Does the study medication Obeticholic Acid improve the overall survival and health
of persons with nonalcoholic fatty liver disease, and resolve NASH?
Basic Study Information
Purpose:Location: University of Rochester Medical Center
Study participation is expected to last between 5-7 years. Participants will be randomized
to take either 10mg, 25mg, or a placebo pill once daily of the study medication. A
liver tissue biopsy is required up to 4 times over the course of the study, and 15
ultrasounds of your belly. Fasting blood work and vital signs will be taken at each
clinic visit. Questionnaires and an EKG of your heart will be periodically done at
clinic visits. All study medication and protocol required procedures are covered by
the clinical trial sponsor.
Study Reference #: 20151635
Lead Researcher (Principal Investigator)
Lead Researcher: Jonathan Huang
Study Contact InformationStudy Coordinator: Chelsea DiBella, MPH
Phone: (585) 275-0803
Additional Study Details
Number of Visits:
More than 10
Trial Not Found
The study you are looking for is not active at this time.
Return to Search